Limited impact of real-world evidence in medical oncology: how can AI turn the tide
Real-world evidence (RWE), derived from real-world health data (RWD) generated during routine clinical practice, is increasingly recognized as a valuable complement to traditional clinical trial data in medical oncology. While randomized controlled trials remain the gold standard for evidence-based...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 October 2025
|
| In: |
European journal of cancer
Year: 2025, Volume: 228, Pages: 1-3 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2025.115714 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ejca.2025.115714 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804925004976 
|
| Author Notes: | Anna Pellat, Jakob Nikolas Kather |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1965060005 | ||
| 003 | DE-627 | ||
| 005 | 20260320160844.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260312s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2025.115714 |2 doi | |
| 035 | |a (DE-627)1965060005 | ||
| 035 | |a (DE-599)KXP1965060005 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pellat, Anna |e VerfasserIn |0 (DE-588)1392721210 |0 (DE-627)1965060625 |4 aut | |
| 245 | 1 | 0 | |a Limited impact of real-world evidence in medical oncology |b how can AI turn the tide |c Anna Pellat, Jakob Nikolas Kather |
| 264 | 1 | |c 1 October 2025 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 15. August 2025, Artikelversion: 27. August 2025 | ||
| 500 | |a Gesehen am 12.03.2026 | ||
| 520 | |a Real-world evidence (RWE), derived from real-world health data (RWD) generated during routine clinical practice, is increasingly recognized as a valuable complement to traditional clinical trial data in medical oncology. While randomized controlled trials remain the gold standard for evidence-based medicine, they often face limitations due to rising costs, ethical constraints, and the inability to cover all treatment combinations and diverse patient populations. The current impact of RWE is limited by several challenges, including data inconsistency, quality issues, and burdensome data collection processes. Despite its role in specific areas like accelerating drug development in rare cancers, RWE has yet to achieve its full potential due to these limitations. Artificial intelligence (AI), particularly through natural language processing and large language models (LLMs), presents a transformative opportunity for RWE. AI technologies can streamline data collection, extraction, cleaning, and analysis, making the process more efficient and accurate. LLMs, for instance, can extract structured data from unstructured text and facilitate the integration of diverse data sources. This automation can significantly reduce the workload on clinicians and improve the consistency and reliability of RWD. These tools can address existing challenges and unlock the full potential of RWD, ultimately leading to improved patient outcomes and more robust oncology research. | ||
| 650 | 4 | |a Artificial intelligence | |
| 650 | 4 | |a Large language models | |
| 650 | 4 | |a Real-world evidence | |
| 700 | 1 | |a Kather, Jakob Nikolas |d 1989- |e VerfasserIn |0 (DE-588)1064064914 |0 (DE-627)812897587 |0 (DE-576)423589091 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 228(2025) vom: Okt., Artikel-ID 115714, Seite 1-3 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a Limited impact of real-world evidence in medical oncology how can AI turn the tide |
| 773 | 1 | 8 | |g volume:228 |g year:2025 |g month:10 |g elocationid:115714 |g pages:1-3 |g extent:3 |a Limited impact of real-world evidence in medical oncology how can AI turn the tide |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2025.115714 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0959804925004976 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260312 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1064064914 |a Kather, Jakob Nikolas |m 1064064914:Kather, Jakob Nikolas |d 910000 |d 910100 |e 910000PK1064064914 |e 910100PK1064064914 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 999 | |a KXP-PPN1965060005 |e 4933848920 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"1 October 2025","dateIssuedKey":"2025"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"part":{"year":"2025","text":"228(2025) vom: Okt., Artikel-ID 115714, Seite 1-3","extent":"3","volume":"228","pages":"1-3"},"titleAlt":[{"title":"EJC online"}],"pubHistory":["28.1992 -"],"recId":"266883400","corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"role":"isb","display":"European Association for Cancer Research"},{"display":"European School of Oncology","role":"isb"}],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1992","publisher":"Elsevier ; Pergamon Press","dateIssuedDisp":"1992-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"issn":["1879-0852"],"eki":["266883400"],"zdb":["1468190-0"]},"title":[{"title":"European journal of cancer","title_sort":"European journal of cancer"}],"disp":"Limited impact of real-world evidence in medical oncology how can AI turn the tideEuropean journal of cancer","language":["eng"]}],"title":[{"title_sort":"Limited impact of real-world evidence in medical oncology","subtitle":"how can AI turn the tide","title":"Limited impact of real-world evidence in medical oncology"}],"id":{"doi":["10.1016/j.ejca.2025.115714"],"eki":["1965060005"]},"language":["eng"],"name":{"displayForm":["Anna Pellat, Jakob Nikolas Kather"]},"recId":"1965060005","physDesc":[{"extent":"3 S."}],"person":[{"display":"Pellat, Anna","role":"aut","given":"Anna","family":"Pellat"},{"family":"Kather","role":"aut","given":"Jakob Nikolas","display":"Kather, Jakob Nikolas"}],"note":["Online verfügbar: 15. August 2025, Artikelversion: 27. August 2025","Gesehen am 12.03.2026"]} | ||
| SRT | |a PELLATANNALIMITEDIMP1202 | ||